Nami Surgical

Summary

About

About Nami Surgical

Nami Surgical is developing miniaturised ultrasonic scalpels for robot-assisted surgery. Its transducer and instrument architecture is intended to place ultrasonic cutting and sealing capability in confined anatomy where conventional hand-held designs are too large or inflexible for compact robotic instruments.

The University of Glasgow spin-out is building a modular driving system that controls energy delivery at the surgical site and a patented miniaturised scalpel developed with robotic surgeons. Initial target procedures span urology, gynaecology and cardiology. The platform remained in development in 2026, with the company preparing cadaver studies and subsequent in-vivo validation before commercial clinical use.

PRICE
Range 1Y
Return
High
Low
Updated

Funding

Investors

  • Eos Advisory - Lead - Angel / Individual - 1 funding event - first seen 2026-01-29
  • Investment Fund for Scotland - Participant - VC - 1 funding event - first seen 2026-01-29
  • Maven Capital Partners - Participant - VC - 1 funding event - first seen 2026-01-29
  • Scottish Enterprise - Participant - Angel / Individual - 1 funding event - first seen 2026-01-29

Team

  • Nikki Palfrey - Chief Executive Officer - Leads Nami's commercial strategy and partner engagement.
  • Nico Fenu - Co-Founder and COO - Oversees operations as Nami moves its miniaturised ultrasonic platform toward commercialisation.
  • Rebecca Cleary - Co-Founder and CTO - Leads technical development of Nami's miniaturised ultrasonic surgical technology.

Timeline

Events

Context

Comparable profiles

Shared workflows

Context tags

  • Surgical instrument manipulation - Capability - Surgical instrument manipulation is a documented company focus.
  • Medical robot components - Stack Layer - Medical robot components is a documented company focus.
  • Robot-assisted procedure workflow - Workflow - Surgical robotics companies is a documented company focus.